Antares Pharma Inc. (ATRS) Declined -7.53% or -0.18 To Price $2.21 On Tuesday


Antares Pharma Inc. (ATRS) declined -7.53% or -0.18 to $2.21. It is around 1.85 million shares traded, which is 143.11% compare to the average total volume 1.29 million. The market cap of ATRS is $346.25 million. The year to date change is 15.46%. The 52 week price range is from $1.58 to $4.09. Price of ATRS have changed 19.50% during last week. It have changed 6.22% over last month, 31.32% over last 3 months, -20.86% over last 6 months and -3.24% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ATRS is 2.09. It is -5.43% below current price. The 200-day Moving Averages for ATRS is 2.59. It is 17.19% above current price. The 52-week High is 4.09. It is 85.07% from the current price. The 52-week Low is 1.58. It is -28.51% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ATRS is 4.29 on 2018-01-31. Short % to float is 2.86%. There are some statistics of ATRS. It is has market cap $346.25 million. The share outstanding is 156.67 million. The average volume is 1.29 million. The revenue is 54.67M. The gross profit is 27.62M. The percent of top 15 Institution holding is 37.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ATRS is -40.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ATRS is -23.00%.


Tags:

Share this post